Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,980 | 748 | 16,712 | 39,971 | 31,566 |
| Marketable Securities | N/A | N/A | 599 | 1,196 | 7,622 |
| Receivables | N/A | N/A | 982 | 1,603 | 1,873 |
| Inventories | N/A | N/A | N/A | 414 | 593 |
| Other current assets | 0 | 10,000 | 7,500 | 0 | 0 |
| TOTAL | $14,778 | $14,166 | $28,161 | $47,343 | $47,180 |
| Non-Current Assets | |||||
| PPE Net | 3,628 | 3,679 | 4,324 | 4,426 | 4,880 |
| Investments And Advances | 0 | 0 | 5,830 | 0 | 0 |
| Intangibles | 17,064 | 17,064 | 17,064 | 31,702 | 32,325 |
| Other Non-Current Assets | 7,760 | 8,024 | 8,864 | 10,275 | 12,433 |
| TOTAL | $28,452 | $28,767 | $36,082 | $46,403 | $49,638 |
| Total Assets | $43,230 | $42,933 | $64,243 | $93,746 | $96,818 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,560 | 1,570 | 757 | 730 | 736 |
| Accounts payable and accrued liabilities | 11,586 | 16,248 | 9,327 | 11,144 | 12,942 |
| Accrued Expenses | 16,686 | 17,468 | 29,308 | 24,944 | 28,170 |
| Other current liabilities | N/A | 1,576 | 2,830 | 2,820 | 8,275 |
| TOTAL | $29,912 | $36,942 | $42,302 | $39,718 | $50,203 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,174 | 1,836 | 2,907 | 9,203 | 9,558 |
| Deferred Revenues | 80 | 80 | 80 | 80 | 80 |
| Other Non-Current Liabilities | 66,454 | 119,119 | 142,404 | 169,495 | 161,028 |
| TOTAL | $68,844 | $121,165 | $145,599 | $179,005 | $170,913 |
| Total Liabilities | $98,756 | $158,107 | $187,901 | $218,723 | $221,116 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,804 | 1,540 | 1,073 | 195 | 47 |
| Common Shares | 1,303,612 | 1,213,661 | 1,188,071 | 1,142,573 | 1,090,376 |
| Retained earnings | -1,352,870 | -1,325,444 | -1,312,320 | -1,270,979 | -1,223,333 |
| Other shareholders' equity | -6,268 | -3,391 | 591 | 3,429 | 8,659 |
| TOTAL | $-55,526 | $-115,174 | $-123,658 | $-124,977 | $-124,298 |
| Total Liabilities And Equity | $43,230 | $42,933 | $64,243 | $93,746 | $96,818 |